[1]
SGHERZA, N. et al. 2024. Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments. Mediterranean Journal of Hematology and Infectious Diseases. 16, 1 (Feb. 2024), e2024022. DOI:https://doi.org/10.4084/MJHID.2024.022.